Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on SatoshiPay disposal to Blue Star

4 Apr 2017 07:00

RNS Number : 4476B
FastForward Innovations Limited
04 April 2017
 

 

4 April 2017 For immediate release

 

 

FastForward Innovations Ltd

("FastForward" or the "Company")

Potential disposal of interest in Blue Star Capital PLC

Blue Star Capital plc ("Blue Star") has agreed that FastForward may no longer bound by the lock-ins and orderly market requirements in respect of its holding of 268,213,880 new ordinary shares of Blue Star (the "Consideration Shares" ) as previously announced on 2 March 2017 subject to Blue Star's broker finalising arrangements to place out the Consideration Shares to a variety of investors on terms that the Blue Star Directors consider are acceptable. Blue Star's announcement is set out in full below.

"Blue Star Capital plc (AIM: BLU), the investing company with a focus on technology and its applications within media and gaming, announces an update following its announcement on 2 March 2017 regarding its further investment in SatoshiPay ("Investment") and issue of 268,213,880 new ordinary shares of Blue Star to FastForward as consideration for the Investment (the "Announcement").

At the time of entering into the SPA regarding the Investment, as a result of the Consideration Shares to be issued to FastForward comprising approximately 21.7 percent. of the issued share capital of the Company, the Directors of Blue Star considered that it was in the best interests of shareholders for the Consideration Shares to be subject to a staged lock-in agreement over a period of 9 months ("lock-in arrangements"). Following the Announcement and completion of the Investment, the Directors believe that the lock-in arrangements may have led to the share price of Blue Star under-performing compared to the Director's expectations whilst shareholders and potential new investors wait for each lock-in period to end. Taking this into account and the strong interest in the Company's placing of new ordinary shares in January 2017, the Directors have agreed that, subject to the broker finalising arrangements to place out the existing Consideration Shares to a variety of investors on terms that the Directors consider are acceptable, the lock-in arrangements may be terminated. The Directors believe that this will be in the best interests of shareholders. The Directors will provide an update in the event that the existing Consideration Shares are successfully placed-out with new shareholders.

Unless otherwise stated, capitalised terms used in this announcement have the meaning as set out in the Announcement."

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 ("MAR")

 

 

For further information please visit www.fstfwd.co or contact:

FastForward Innovations Limited

info@fstfwd.co

Josh Epstein / Ian Burns

 

Beaumont Cornish Limited (Nomad)

James Biddle / Roland Cornish

Tel: +44 207 628 3396

 

Optiva Securities Limited (Broker)

Ed McDermott/ Jeremy King

Tel: +44 (0) 203 137 1902

 

CAUTIONARY STATEMENT

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of Fast Forward Innovations Ltd. There can be no assurance that such statements will prove to be accurate, achievable or recognizable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. Fast Forward Innovations assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISUOVBRBWASRAR
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.